Share Price and Basic Stock Data
Last Updated: December 9, 2025, 4:49 pm
| PEG Ratio | 0.94 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Krishana Phoschem Ltd operates in the fertilisers sector, an industry that is integral to India’s agricultural backbone. As of the latest financial year ending March 2025, the company reported sales of ₹1,358 Cr, a significant jump from ₹323 Cr in March 2023. This growth trajectory is impressive, especially considering the volatile nature of agricultural inputs. The revenue has shown a remarkable upward trend, with quarterly sales peaking at ₹301 Cr in September 2024. Such figures indicate a robust demand for its products, likely driven by the increasing need for fertilisers to boost crop yields amidst rising food security concerns. However, the company also experienced fluctuations in sales, as seen in the dip to ₹47 Cr in December 2022, highlighting the cyclical nature of the sector. Overall, the revenue growth seems promising, positioning Krishana Phoschem as a key player in the fertiliser market.
Profitability and Efficiency Metrics
When it comes to profitability, Krishana Phoschem’s numbers tell a compelling story. The net profit saw a substantial surge to ₹87 Cr in March 2025, up from ₹27 Cr the previous year, reflecting a healthy net profit margin of 6.37%. The company’s operating profit margin (OPM) has hovered around 14%, suggesting reasonable efficiency in managing production costs. However, OPM dipped to 10% in both March 2024 and March 2025, indicating potential pressures from rising input costs or operational inefficiencies. The interest coverage ratio stood at 4.91x, which appears strong, allowing the company to comfortably meet its interest obligations despite increasing borrowings. This combination of rising profits and reasonable efficiency metrics indicates that Krishana Phoschem is navigating the challenges of the fertiliser industry effectively, though it must keep a close eye on expense management to sustain profitability.
Balance Sheet Strength and Financial Ratios
Krishana Phoschem’s balance sheet presents a mixed picture. On one hand, the company has reported reserves of ₹322 Cr, showcasing a solid foundation for future growth. On the other hand, total borrowings stood at ₹376 Cr, which raises some concerns about leverage. The debt-to-equity ratio of 0.97x suggests that the company is relatively close to a balanced capital structure, but it could be seen as stretched compared to industry norms. The return on equity (ROE) at 25.3% is impressive, indicating effective use of shareholders’ funds. Additionally, the return on capital employed (ROCE) of 21.7% reinforces the notion that the firm is efficiently generating returns from its capital investments. However, with a cash conversion cycle of 95 days, the company must manage its working capital effectively to avoid liquidity issues in the future.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Krishana Phoschem reflects a growing confidence among its promoters and the public. Promoters hold a substantial 71.96% stake, which provides a sense of stability and commitment to the company’s long-term vision. Notably, foreign institutional investors (FIIs) have recently begun to enter the stock, albeit at a modest 0.60%. The increase in the number of shareholders from 6,289 in December 2022 to 13,987 in September 2025 indicates rising interest from retail investors. This growing public participation can be seen as a positive signal, suggesting that more investors are recognizing the potential within the company. However, the relatively low institutional ownership might imply that larger investors are still cautious, which could be a risk if the company faces any operational challenges.
Outlook, Risks, and Final Insight
The outlook for Krishana Phoschem appears cautiously optimistic, driven by robust revenue growth and improving profitability. However, risks remain, particularly related to the volatility of raw material prices and the cyclical nature of the fertiliser market. The company must navigate these challenges while managing its debt levels to maintain financial health. Additionally, as the sector becomes increasingly competitive, Krishana Phoschem will need to innovate and enhance its product offerings to sustain its market position. For investors, the key will be to weigh the company’s growth potential against these inherent risks. A focus on operational efficiency and strategic expansions could serve as catalysts for further growth, but the market dynamics will play a crucial role in shaping the company’s future performance. Overall, a balanced perspective is essential for anyone considering an investment in Krishana Phoschem Ltd.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Krishana Phoschem Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Gujarat State Fertilizers & Chemicals Ltd | 6,854 Cr. | 172 | 231/156 | 10.3 | 313 | 2.96 % | 6.18 % | 4.77 % | 2.00 |
| Bharat Agri Fert & Realty Ltd | 161 Cr. | 30.4 | 81.2/29.9 | 9.97 | 0.00 % | 6.14 % | 14.8 % | 1.00 | |
| Basant Agro Tech (India) Ltd | 112 Cr. | 12.3 | 20.1/11.0 | 22.2 | 20.0 | 0.41 % | 6.52 % | 2.36 % | 1.00 |
| Zuari Agro Chemicals Ltd | 1,213 Cr. | 289 | 395/155 | 3.51 | 602 | 0.00 % | 12.7 % | 9.06 % | 10.0 |
| Southern Petrochemicals Industries Corporation Ltd (SPIC) | 1,634 Cr. | 80.4 | 128/66.2 | 8.79 | 63.8 | 2.49 % | 16.9 % | 13.8 % | 10.0 |
| Industry Average | 10,534.62 Cr | 391.68 | 47.74 | 185.72 | 0.99% | 13.03% | 10.58% | 6.96 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 66 | 65 | 47 | 145 | 165 | 265 | 230 | 263 | 281 | 301 | 304 | 473 | 396 |
| Expenses | 57 | 50 | 38 | 127 | 133 | 218 | 207 | 238 | 239 | 260 | 260 | 417 | 330 |
| Operating Profit | 9 | 15 | 9 | 19 | 32 | 47 | 24 | 26 | 42 | 40 | 44 | 56 | 66 |
| OPM % | 14% | 24% | 18% | 13% | 20% | 18% | 10% | 10% | 15% | 13% | 15% | 12% | 17% |
| Other Income | 1 | 0 | 1 | 1 | 1 | -1 | 0 | 1 | 1 | 2 | 2 | 6 | 3 |
| Interest | 1 | 2 | 1 | 3 | 7 | 10 | 9 | 11 | 12 | 10 | 9 | 8 | 9 |
| Depreciation | 2 | 2 | 2 | 2 | 8 | 8 | 9 | 8 | 8 | 8 | 8 | 8 | 8 |
| Profit before tax | 7 | 12 | 6 | 14 | 18 | 28 | 6 | 7 | 23 | 25 | 29 | 47 | 51 |
| Tax % | 17% | 17% | 18% | 56% | 33% | 32% | 41% | 17% | 28% | 32% | 29% | 30% | 40% |
| Net Profit | 6 | 10 | 5 | 6 | 12 | 19 | 4 | 6 | 16 | 17 | 21 | 33 | 31 |
| EPS in Rs | 1.03 | 1.65 | 0.78 | 1.05 | 2.00 | 3.25 | 0.61 | 0.92 | 2.71 | 2.76 | 3.39 | 5.43 | 5.05 |
Last Updated: August 1, 2025, 6:10 pm
Below is a detailed analysis of the quarterly data for Krishana Phoschem Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 396.00 Cr.. The value appears to be declining and may need further review. It has decreased from 473.00 Cr. (Mar 2025) to 396.00 Cr., marking a decrease of 77.00 Cr..
- For Expenses, as of Jun 2025, the value is 330.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 417.00 Cr. (Mar 2025) to 330.00 Cr., marking a decrease of 87.00 Cr..
- For Operating Profit, as of Jun 2025, the value is 66.00 Cr.. The value appears strong and on an upward trend. It has increased from 56.00 Cr. (Mar 2025) to 66.00 Cr., marking an increase of 10.00 Cr..
- For OPM %, as of Jun 2025, the value is 17.00%. The value appears strong and on an upward trend. It has increased from 12.00% (Mar 2025) to 17.00%, marking an increase of 5.00%.
- For Other Income, as of Jun 2025, the value is 3.00 Cr.. The value appears to be declining and may need further review. It has decreased from 6.00 Cr. (Mar 2025) to 3.00 Cr., marking a decrease of 3.00 Cr..
- For Interest, as of Jun 2025, the value is 9.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 8.00 Cr. (Mar 2025) to 9.00 Cr., marking an increase of 1.00 Cr..
- For Depreciation, as of Jun 2025, the value is 8.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 8.00 Cr..
- For Profit before tax, as of Jun 2025, the value is 51.00 Cr.. The value appears strong and on an upward trend. It has increased from 47.00 Cr. (Mar 2025) to 51.00 Cr., marking an increase of 4.00 Cr..
- For Tax %, as of Jun 2025, the value is 40.00%. The value appears to be increasing, which may not be favorable. It has increased from 30.00% (Mar 2025) to 40.00%, marking an increase of 10.00%.
- For Net Profit, as of Jun 2025, the value is 31.00 Cr.. The value appears to be declining and may need further review. It has decreased from 33.00 Cr. (Mar 2025) to 31.00 Cr., marking a decrease of 2.00 Cr..
- For EPS in Rs, as of Jun 2025, the value is 5.05. The value appears to be declining and may need further review. It has decreased from 5.43 (Mar 2025) to 5.05, marking a decrease of 0.38.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: July 22, 2025, 3:29 pm
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 90 | 73 | 89 | 80 | 96 | 146 | 162 | 188 | 318 | 323 | 924 | 1,358 | 1,473 |
| Expenses | 75 | 63 | 77 | 64 | 77 | 112 | 127 | 149 | 263 | 271 | 795 | 1,174 | 1,267 |
| Operating Profit | 15 | 10 | 12 | 15 | 19 | 33 | 35 | 39 | 56 | 52 | 129 | 184 | 206 |
| OPM % | 17% | 13% | 13% | 19% | 20% | 23% | 22% | 21% | 17% | 16% | 14% | 14% | 14% |
| Other Income | 0 | 4 | 2 | 1 | 1 | 0 | 0 | 2 | 1 | 3 | 1 | 10 | 13 |
| Interest | 4 | 5 | 5 | 4 | 6 | 3 | 3 | 2 | 4 | 7 | 37 | 39 | 37 |
| Depreciation | 4 | 3 | 6 | 6 | 8 | 11 | 12 | 10 | 10 | 9 | 34 | 31 | 31 |
| Profit before tax | 8 | 5 | 3 | 6 | 6 | 19 | 21 | 28 | 43 | 39 | 59 | 123 | 152 |
| Tax % | 33% | 43% | 54% | 46% | 44% | 29% | 34% | 31% | 31% | 31% | 32% | 30% | |
| Net Profit | 5 | 3 | 1 | 3 | 4 | 14 | 14 | 20 | 29 | 27 | 40 | 87 | 101 |
| EPS in Rs | 1.40 | 0.70 | 0.33 | 0.66 | 0.71 | 2.71 | 2.77 | 3.75 | 4.97 | 4.51 | 6.68 | 14.29 | 16.63 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 9% | 7% | 5% | 6% | 8% | 0% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -40.00% | -66.67% | 200.00% | 33.33% | 250.00% | 0.00% | 42.86% | 45.00% | -6.90% | 48.15% | 117.50% |
| Change in YoY Net Profit Growth (%) | 0.00% | -26.67% | 266.67% | -166.67% | 216.67% | -250.00% | 42.86% | 2.14% | -51.90% | 55.04% | 69.35% |
Krishana Phoschem Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 34% |
| 5 Years: | 53% |
| 3 Years: | 62% |
| TTM: | 42% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 40% |
| 5 Years: | 44% |
| 3 Years: | 43% |
| TTM: | 124% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | 81% |
| 3 Years: | 53% |
| 1 Year: | 120% |
| Return on Equity | |
|---|---|
| 10 Years: | 14% |
| 5 Years: | 17% |
| 3 Years: | 18% |
| Last Year: | 25% |
Last Updated: September 5, 2025, 9:25 am
Balance Sheet
Last Updated: September 10, 2025, 1:59 pm
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 18 | 21 | 21 | 25 | 25 | 25 | 25 | 26 | 30 | 31 | 62 | 62 |
| Reserves | 48 | 52 | 59 | 68 | 71 | 85 | 100 | 121 | 191 | 231 | 239 | 322 |
| Borrowings | 29 | 30 | 32 | 46 | 42 | 32 | 12 | 21 | 70 | 276 | 436 | 376 |
| Other Liabilities | 18 | 19 | 5 | 14 | 11 | 29 | 21 | 27 | 39 | 44 | 108 | 276 |
| Total Liabilities | 112 | 122 | 117 | 152 | 149 | 170 | 158 | 195 | 330 | 582 | 845 | 1,036 |
| Fixed Assets | 74 | 72 | 72 | 80 | 112 | 106 | 96 | 94 | 85 | 358 | 322 | 295 |
| CWIP | 0 | 9 | 8 | 25 | 0 | 1 | 0 | 7 | 92 | 3 | 43 | 78 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 38 | 42 | 37 | 48 | 37 | 64 | 62 | 94 | 153 | 220 | 479 | 664 |
| Total Assets | 112 | 122 | 117 | 152 | 149 | 170 | 158 | 195 | 330 | 582 | 845 | 1,036 |
Below is a detailed analysis of the balance sheet data for Krishana Phoschem Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Equity Capital, as of Mar 2025, the value is 62.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 62.00 Cr..
- For Reserves, as of Mar 2025, the value is 322.00 Cr.. The value appears strong and on an upward trend. It has increased from 239.00 Cr. (Mar 2024) to 322.00 Cr., marking an increase of 83.00 Cr..
- For Borrowings, as of Mar 2025, the value is 376.00 Cr.. The value appears to be improving (decreasing). However, Borrowings exceed Reserves, which may signal higher financial risk. It has decreased from 436.00 Cr. (Mar 2024) to 376.00 Cr., marking a decrease of 60.00 Cr..
- For Other Liabilities, as of Mar 2025, the value is 276.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 108.00 Cr. (Mar 2024) to 276.00 Cr., marking an increase of 168.00 Cr..
- For Total Liabilities, as of Mar 2025, the value is 1,036.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 845.00 Cr. (Mar 2024) to 1,036.00 Cr., marking an increase of 191.00 Cr..
- For Fixed Assets, as of Mar 2025, the value is 295.00 Cr.. The value appears to be declining and may need further review. It has decreased from 322.00 Cr. (Mar 2024) to 295.00 Cr., marking a decrease of 27.00 Cr..
- For CWIP, as of Mar 2025, the value is 78.00 Cr.. The value appears strong and on an upward trend. It has increased from 43.00 Cr. (Mar 2024) to 78.00 Cr., marking an increase of 35.00 Cr..
- For Investments, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
- For Other Assets, as of Mar 2025, the value is 664.00 Cr.. The value appears strong and on an upward trend. It has increased from 479.00 Cr. (Mar 2024) to 664.00 Cr., marking an increase of 185.00 Cr..
- For Total Assets, as of Mar 2025, the value is 1,036.00 Cr.. The value appears strong and on an upward trend. It has increased from 845.00 Cr. (Mar 2024) to 1,036.00 Cr., marking an increase of 191.00 Cr..
However, the Borrowings (376.00 Cr.) are higher than the Reserves (322.00 Cr.), which may signal higher financial risk.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -14.00 | -20.00 | -20.00 | -31.00 | -23.00 | 1.00 | 23.00 | 18.00 | -14.00 | -224.00 | -307.00 | -192.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 8 | 24 | 62 | 66 | 52 | 53 | 41 | 54 | 60 | 84 | 104 | 102 |
| Inventory Days | 223 | 290 | 97 | 224 | 127 | 157 | 135 | 145 | 103 | 194 | 84 | 60 |
| Days Payable | 72 | 115 | 20 | 94 | 43 | 85 | 22 | 41 | 39 | 16 | 35 | 67 |
| Cash Conversion Cycle | 159 | 200 | 139 | 195 | 136 | 126 | 154 | 158 | 124 | 263 | 154 | 95 |
| Working Capital Days | 17 | 36 | 49 | 57 | 22 | 52 | 87 | 95 | 95 | 64 | 44 | 42 |
| ROCE % | 14% | 11% | 7% | 8% | 9% | 16% | 17% | 20% | 20% | 11% | 15% | 22% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 14.00 | 6.54 | 8.80 | 10.50 | 7.83 |
| Diluted EPS (Rs.) | 14.00 | 6.54 | 8.65 | 10.42 | 7.15 |
| Cash EPS (Rs.) | 19.04 | 12.07 | 11.46 | 13.34 | 11.43 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 62.08 | 48.62 | 84.69 | 74.58 | 56.36 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 62.08 | 48.62 | 84.69 | 74.58 | 56.36 |
| Dividend / Share (Rs.) | 0.50 | 0.50 | 0.50 | 0.50 | 0.50 |
| Revenue From Operations / Share (Rs.) | 219.68 | 149.43 | 104.43 | 107.75 | 72.31 |
| PBDIT / Share (Rs.) | 31.36 | 21.02 | 17.61 | 19.20 | 15.68 |
| PBIT / Share (Rs.) | 26.32 | 15.50 | 14.80 | 15.80 | 11.75 |
| PBT / Share (Rs.) | 19.94 | 9.55 | 12.60 | 14.43 | 10.88 |
| Net Profit / Share (Rs.) | 14.00 | 6.54 | 8.65 | 9.94 | 7.50 |
| PBDIT Margin (%) | 14.27 | 14.06 | 16.86 | 17.81 | 21.67 |
| PBIT Margin (%) | 11.98 | 10.37 | 14.17 | 14.66 | 16.25 |
| PBT Margin (%) | 9.07 | 6.39 | 12.06 | 13.39 | 15.04 |
| Net Profit Margin (%) | 6.37 | 4.37 | 8.28 | 9.22 | 10.37 |
| Return on Networth / Equity (%) | 22.54 | 13.45 | 10.21 | 13.32 | 13.31 |
| Return on Capital Employeed (%) | 27.68 | 19.62 | 10.73 | 16.87 | 19.03 |
| Return On Assets (%) | 8.35 | 4.78 | 4.59 | 8.93 | 10.01 |
| Long Term Debt / Equity (X) | 0.34 | 0.52 | 0.55 | 0.22 | 0.04 |
| Total Debt / Equity (X) | 0.97 | 1.45 | 1.06 | 0.31 | 0.10 |
| Asset Turnover Ratio (%) | 1.44 | 1.29 | 0.70 | 1.22 | 1.07 |
| Current Ratio (X) | 1.41 | 1.33 | 1.36 | 2.58 | 2.43 |
| Quick Ratio (X) | 1.08 | 0.92 | 0.65 | 1.52 | 1.24 |
| Inventory Turnover Ratio (X) | 9.33 | 4.61 | 1.86 | 3.14 | 2.57 |
| Dividend Payout Ratio (NP) (%) | 3.57 | 3.82 | 5.54 | 4.64 | 6.35 |
| Dividend Payout Ratio (CP) (%) | 2.62 | 2.07 | 4.18 | 3.46 | 4.17 |
| Earning Retention Ratio (%) | 96.43 | 96.18 | 94.46 | 95.36 | 93.65 |
| Cash Earning Retention Ratio (%) | 97.38 | 97.93 | 95.82 | 96.54 | 95.83 |
| Interest Coverage Ratio (X) | 4.91 | 3.54 | 7.98 | 14.05 | 17.99 |
| Interest Coverage Ratio (Post Tax) (X) | 3.19 | 2.10 | 4.92 | 8.27 | 9.61 |
| Enterprise Value (Cr.) | 1801.75 | 1938.86 | 1779.52 | 892.61 | 259.52 |
| EV / Net Operating Revenue (X) | 1.33 | 2.10 | 5.51 | 2.79 | 1.38 |
| EV / EBITDA (X) | 9.29 | 14.92 | 32.69 | 15.69 | 6.34 |
| MarketCap / Net Operating Revenue (X) | 1.07 | 1.63 | 4.66 | 2.58 | 1.30 |
| Retention Ratios (%) | 96.42 | 96.17 | 94.45 | 95.35 | 93.64 |
| Price / BV (X) | 3.79 | 5.02 | 5.74 | 3.73 | 1.66 |
| Price / Net Operating Revenue (X) | 1.07 | 1.63 | 4.66 | 2.58 | 1.30 |
| EarningsYield | 0.05 | 0.02 | 0.01 | 0.03 | 0.08 |
After reviewing the key financial ratios for Krishana Phoschem Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 14.00. This value is within the healthy range. It has increased from 6.54 (Mar 24) to 14.00, marking an increase of 7.46.
- For Diluted EPS (Rs.), as of Mar 25, the value is 14.00. This value is within the healthy range. It has increased from 6.54 (Mar 24) to 14.00, marking an increase of 7.46.
- For Cash EPS (Rs.), as of Mar 25, the value is 19.04. This value is within the healthy range. It has increased from 12.07 (Mar 24) to 19.04, marking an increase of 6.97.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 62.08. It has increased from 48.62 (Mar 24) to 62.08, marking an increase of 13.46.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 62.08. It has increased from 48.62 (Mar 24) to 62.08, marking an increase of 13.46.
- For Dividend / Share (Rs.), as of Mar 25, the value is 0.50. This value is below the healthy minimum of 1. There is no change compared to the previous period (Mar 24) which recorded 0.50.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 219.68. It has increased from 149.43 (Mar 24) to 219.68, marking an increase of 70.25.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 31.36. This value is within the healthy range. It has increased from 21.02 (Mar 24) to 31.36, marking an increase of 10.34.
- For PBIT / Share (Rs.), as of Mar 25, the value is 26.32. This value is within the healthy range. It has increased from 15.50 (Mar 24) to 26.32, marking an increase of 10.82.
- For PBT / Share (Rs.), as of Mar 25, the value is 19.94. This value is within the healthy range. It has increased from 9.55 (Mar 24) to 19.94, marking an increase of 10.39.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 14.00. This value is within the healthy range. It has increased from 6.54 (Mar 24) to 14.00, marking an increase of 7.46.
- For PBDIT Margin (%), as of Mar 25, the value is 14.27. This value is within the healthy range. It has increased from 14.06 (Mar 24) to 14.27, marking an increase of 0.21.
- For PBIT Margin (%), as of Mar 25, the value is 11.98. This value is within the healthy range. It has increased from 10.37 (Mar 24) to 11.98, marking an increase of 1.61.
- For PBT Margin (%), as of Mar 25, the value is 9.07. This value is below the healthy minimum of 10. It has increased from 6.39 (Mar 24) to 9.07, marking an increase of 2.68.
- For Net Profit Margin (%), as of Mar 25, the value is 6.37. This value is within the healthy range. It has increased from 4.37 (Mar 24) to 6.37, marking an increase of 2.00.
- For Return on Networth / Equity (%), as of Mar 25, the value is 22.54. This value is within the healthy range. It has increased from 13.45 (Mar 24) to 22.54, marking an increase of 9.09.
- For Return on Capital Employeed (%), as of Mar 25, the value is 27.68. This value is within the healthy range. It has increased from 19.62 (Mar 24) to 27.68, marking an increase of 8.06.
- For Return On Assets (%), as of Mar 25, the value is 8.35. This value is within the healthy range. It has increased from 4.78 (Mar 24) to 8.35, marking an increase of 3.57.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.34. This value is within the healthy range. It has decreased from 0.52 (Mar 24) to 0.34, marking a decrease of 0.18.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.97. This value is within the healthy range. It has decreased from 1.45 (Mar 24) to 0.97, marking a decrease of 0.48.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 1.44. It has increased from 1.29 (Mar 24) to 1.44, marking an increase of 0.15.
- For Current Ratio (X), as of Mar 25, the value is 1.41. This value is below the healthy minimum of 1.5. It has increased from 1.33 (Mar 24) to 1.41, marking an increase of 0.08.
- For Quick Ratio (X), as of Mar 25, the value is 1.08. This value is within the healthy range. It has increased from 0.92 (Mar 24) to 1.08, marking an increase of 0.16.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 9.33. This value exceeds the healthy maximum of 8. It has increased from 4.61 (Mar 24) to 9.33, marking an increase of 4.72.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 3.57. This value is below the healthy minimum of 20. It has decreased from 3.82 (Mar 24) to 3.57, marking a decrease of 0.25.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 2.62. This value is below the healthy minimum of 20. It has increased from 2.07 (Mar 24) to 2.62, marking an increase of 0.55.
- For Earning Retention Ratio (%), as of Mar 25, the value is 96.43. This value exceeds the healthy maximum of 70. It has increased from 96.18 (Mar 24) to 96.43, marking an increase of 0.25.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 97.38. This value exceeds the healthy maximum of 70. It has decreased from 97.93 (Mar 24) to 97.38, marking a decrease of 0.55.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 4.91. This value is within the healthy range. It has increased from 3.54 (Mar 24) to 4.91, marking an increase of 1.37.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 3.19. This value is within the healthy range. It has increased from 2.10 (Mar 24) to 3.19, marking an increase of 1.09.
- For Enterprise Value (Cr.), as of Mar 25, the value is 1,801.75. It has decreased from 1,938.86 (Mar 24) to 1,801.75, marking a decrease of 137.11.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.33. This value is within the healthy range. It has decreased from 2.10 (Mar 24) to 1.33, marking a decrease of 0.77.
- For EV / EBITDA (X), as of Mar 25, the value is 9.29. This value is within the healthy range. It has decreased from 14.92 (Mar 24) to 9.29, marking a decrease of 5.63.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.07. This value is within the healthy range. It has decreased from 1.63 (Mar 24) to 1.07, marking a decrease of 0.56.
- For Retention Ratios (%), as of Mar 25, the value is 96.42. This value exceeds the healthy maximum of 70. It has increased from 96.17 (Mar 24) to 96.42, marking an increase of 0.25.
- For Price / BV (X), as of Mar 25, the value is 3.79. This value exceeds the healthy maximum of 3. It has decreased from 5.02 (Mar 24) to 3.79, marking a decrease of 1.23.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.07. This value is within the healthy range. It has decreased from 1.63 (Mar 24) to 1.07, marking a decrease of 0.56.
- For EarningsYield, as of Mar 25, the value is 0.05. This value is below the healthy minimum of 5. It has increased from 0.02 (Mar 24) to 0.05, marking an increase of 0.03.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Krishana Phoschem Ltd:
- Net Profit Margin: 6.37%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 27.68% (Industry Average ROCE: 12.46%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 22.54% (Industry Average ROE: 9.66%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 3.19
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.08
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 25.6 (Industry average Stock P/E: 41.51)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.97
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 6.37%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Fertilisers | Wing A/2, 1st Floor, Ostwal Heights, Urban Forest, Atun, Bhilwara Rajasthan 311802 | secretarial@krishnaphoschem.com http://www.krishnaphoschem.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Mahendra Kumar Ostwal | Chairman & Non-Exe.Director |
| Mr. Praveen Ostwal | Managing Director |
| Mr. Sunil Kothari | WholeTime Director & CFO |
| Mr. Pankaj Ostwal | Non Executive Director |
| Mr. Bheru Lal Ostwal | Independent Director |
| Mrs. Shruti Babel | Independent Director |
| Mr. Gopal Inani | Independent Director |
| Mrs. Priyanka Surana | Independent Director |
FAQ
What is the intrinsic value of Krishana Phoschem Ltd?
Krishana Phoschem Ltd's intrinsic value (as of 09 December 2025) is 380.70 which is 23.25% lower the current market price of 496.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 3,002 Cr. market cap, FY2025-2026 high/low of 619/175, reserves of ₹322 Cr, and liabilities of 1,036 Cr.
What is the Market Cap of Krishana Phoschem Ltd?
The Market Cap of Krishana Phoschem Ltd is 3,002 Cr..
What is the current Stock Price of Krishana Phoschem Ltd as on 09 December 2025?
The current stock price of Krishana Phoschem Ltd as on 09 December 2025 is 496.
What is the High / Low of Krishana Phoschem Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Krishana Phoschem Ltd stocks is 619/175.
What is the Stock P/E of Krishana Phoschem Ltd?
The Stock P/E of Krishana Phoschem Ltd is 25.6.
What is the Book Value of Krishana Phoschem Ltd?
The Book Value of Krishana Phoschem Ltd is 73.4.
What is the Dividend Yield of Krishana Phoschem Ltd?
The Dividend Yield of Krishana Phoschem Ltd is 0.10 %.
What is the ROCE of Krishana Phoschem Ltd?
The ROCE of Krishana Phoschem Ltd is 21.7 %.
What is the ROE of Krishana Phoschem Ltd?
The ROE of Krishana Phoschem Ltd is 25.3 %.
What is the Face Value of Krishana Phoschem Ltd?
The Face Value of Krishana Phoschem Ltd is 10.0.